Bromelain-digested casein peptide pool (BDCPP) as a natural neuroprotective compound: an in silico study to explain its mechanism of action
Amino Acids · 16.11.2026
DOI: 10.1007/s00726-026-03572-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Amino Acids, online erschienen am 16.11.2026. Verfasst von Zeynab Mohamadi Yarijani und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Semnan University of Medical Sciences and Health Services, National Institute for Medical Research Development.
Abstract (Originalsprache)
Bromelain-digested casein peptide pool (BDCPP) has been shown to alleviate chronic stress-induced behavioral and neurobiological alterations in rats; however, the molecular basis of these effects remains unclear. In the present study, an integrated in silico approach was used to investigate the possible neuroprotective mechanisms of BDCPP. Peptides generated following simulated bromelain digestion of casein were screened for safety, gastrointestinal stability, physicochemical properties, and predicted neuroprotective activities. We identified 11 peptides with favorable characteristics and selected two representative peptides (β-casein-P2 and κ-casein-P19 ) for molecular docking and molecular dynamics analyses. Both peptides showed strong and stable interactions with dipeptidyl peptidase-4 (DPP4) and glutamate carboxypeptidase II (GCPII), proteins involved in gut–brain axis communication, neuroinflammation, and glutamatergic signaling. Molecular dynamics simulations suggested the stability of the selected peptide–receptor complexes throughout the simulation period. Importantly, several peptides within the BDCPP pool displayed similar predicted biological activities, suggesting that the observed effects of BDCPP are likely mediated by the collective action of multiple bioactive peptides rather than a single dominant component. The identified interactions with DPP4 and GCPII may provide a potential molecular basis for the previously reported behavioral, cognitive, and neurobiological benefits of BDCPP and support its potential as a food-derived neuroprotective ingredient. However, these computational predictions should be considered as a hypothesis-generating framework and require further experimental validation. Graphical abstract A proposed neuroprotection pathway begins with bromelain digestion of casein proteins. Computer-based screening selects peptides P2 and P19, which are docked with DPP4, GCPII, and TLR4 and assessed using molecular dynamics simulations. The figure links these targets to reduced neuroinflammation, increased neuroplasticity, modulation of glutamatergic signaling, metabolic regulation, and improved behavior, cognition, and mood.
Förderung
- Semnan University of Medical Sciences and Health Services
- National Institute for Medical Research Development
Zitieren
APA
Yarijani, Z. M., Raise-Abdullahi, P., Shahbazi, B., Madanchi, H., & Rashidy-Pour, A. (2026). Bromelain-digested casein peptide pool (BDCPP) as a natural neuroprotective compound: an in silico study to explain its mechanism of action. Amino Acids. https://doi.org/10.1007/s00726-026-03572-8
Vancouver
Yarijani ZM, Raise-Abdullahi P, Shahbazi B, Madanchi H, Rashidy-Pour A. Bromelain-digested casein peptide pool (BDCPP) as a natural neuroprotective compound: an in silico study to explain its mechanism of action. Amino Acids. 2026. doi:10.1007/s00726-026-03572-8
BibTeX
@article{Yarijani2026,
author = {Yarijani, Zeynab Mohamadi and Raise-Abdullahi, Payman and Shahbazi, Behzad and Madanchi, Hamid and Rashidy-Pour, Ali},
title = {Bromelain-digested casein peptide pool (BDCPP) as a natural neuroprotective compound: an in silico study to explain its mechanism of action},
journal = {Amino Acids},
year = {2026},
doi = {10.1007/s00726-026-03572-8}
}
EUVIMED